Up a level |
Lu, Shun and Shih, Jin-Yuan and Jang, Tae-Won and Liam, Chong-Kin and Yu, Yongfeng (2021) Afatinib as first-line treatment in Asian patients with EGFR mutation-positive NSCLC: A narrative review of real-world evidence. Advances in Therapy, 38 (5). pp. 2038-2053. ISSN 0741-238X,